학술논문
Hyperactivated mTOR Signaling Is a Characteristic Feature of High Risk Acute Lymphoblastic Leukemia and Can Be Effectively Targeted in a Preclinical NOD/SCID/huALL Xenograft Mouse Model
Document Type
Abstract
Author
Source
In Blood 18 November 2011 118(21):2572-2572
Subject
Language
ISSN
0006-4971